Skip to main content
Menu
Viral Vector Center of Excellence

Viral Vector Center of Excellence

Your vector challenges. Our shared mission.

An integrated innovation and production hub advancing viral vector design, engineering, and manufacturing to support developers from early discovery through scalable process development.

A commercial license is required for any clinical or commercial application involving AAVs developed using Revvity technologies.

Core capabilities

Viral vector center of excellence capabilities:

  • Tropism
  • Payload expression
  • Manufacturing
  • Analytics

What makes this different

Traditional approach Viral vector center of excellence
Manufacturing provider Scientific innovation hub
Transactional relationship Collaborative partnership
Fragmented services Integrated platform
Execution-focused Guidance-driven development

Expertise that strengthens every stage of development

We support viral vector programs as they evolve across the full development journey:

  • Early vector design and feasibility
  • Engineering and optimization
  • Process development
  • Scale-up readiness
  • Ongoing scientific collaboration and problem-solving

The goal is simple: reduce friction between stages and help teams move forward with confidence.

Why Munich

Munich is more than a location, it is a concentration of expertise.

Leveraging decades of experience in viral vector engineering and manufacturing, incorporating the expertise of SIRION Biotech within Revvity Viral vector center of excellence, the site brings together strong foundations in both AAV and lentiviral systems, supported by advanced engineering platforms and enabling technologies.

This combination creates an environment where scientific depth and operational capability intersect, supporting more informed development decisions and more efficient program progression.

Revvity AI Assistant Beta